Retatrutide is widely viewed as a potential next efficacy benchmark ahead of its expected 2027/28 launch
Both drug classes were equally effective in reducing combined major adverse cardiac events such as heart attack, stroke, and death from cardiovascular disease, compared to people with diabetes who were not taking the drugs.[3] The rate of hospitalization for heart failure was 32% less in patients taking SGLT2 inhibitors compared to patients not taking the drugs, especially in those with more severe cardiovascular disease risk
GABA & L-Theanine (The Counter-Signal) If the GLP-1 medication is pushing the "gas pedal" (Orexin), GABA and L-Theanine act as the brake pedal
It is a strong option for women on GLP-1 because it offers: more intentional daily nutrient support women-focused formulation twice-daily dosing bioavailable nutrients support for energy, metabolism, hair, skin, and overall wellness For women who are eating less and want a more comprehensive multivitamin while on GLP-1, Womens Twice Daily is a better fit than many standard multivitamins that do little more than provide a basic label claim